Roberto Colotti1, Jessica A M Bastiaansen1, Anne Wilson2, Ulrich Flögel3, Christine Gonzales4, Juerg Schwitter4, Matthias Stuber1,5, Ruud B van Heeswijk1. 1. Department of Radiology, University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland. 2. Ludwig Center for Cancer Research, University of Lausanne (UNIL), Epalinges, Switzerland. 3. Department of Cardiovascular Physiology, Heinrich Heine University, Düsseldorf, Germany. 4. Division of Cardiology and Cardiac MR Center, Department of Internal Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. 5. Center for Biomedical Imaging (CIBM), Lausanne and Geneva, Switzerland.
Abstract
PURPOSE: To characterize and optimize 19 F MRI for different perfluorocarbons (PFCs) at 3T and quantify the loss of acquisition efficiency as a function of different temperature and cellular conditions. METHODS: The T1 and T2 relaxation times of the commonly used PFCs perfluoropolyether (PFPE), perfluoro-15-crown-5-ether (PFCE), and perfluorooctyl bromide (PFOB) were measured in phantoms and in several different conditions (cell types, presence of fixation agent, and temperatures). These relaxation times were used to optimize pulse sequences through numerical simulations. The acquisition efficiency in each cellular condition was then determined as the ratio of the signal after optimization with the reference relaxation times and after optimization with its proper relaxation times. Finally, PFC detection limits were determined. RESULTS: The loss of acquisition efficiency due to parameter settings optimized for the wrong temperature and cellular condition was limited to 13%. The detection limits of all PFCs were lower at 24 °C than at 37 °C and varied from 11.8 ± 3.0 mM for PFCE at 24 °C to 379.9 ± 51.8 mM for PFOB at 37 °C. CONCLUSION: Optimizing 19 F pulse sequences with a known phantom only leads to moderate loss in acquisition efficiency in cellular conditions that might be encountered in in vivo and in vitro experiments. Magn Reson Med 77:2263-2271, 2017.
PURPOSE: To characterize and optimize 19 F MRI for different perfluorocarbons (PFCs) at 3T and quantify the loss of acquisition efficiency as a function of different temperature and cellular conditions. METHODS: The T1 and T2 relaxation times of the commonly used PFCs perfluoropolyether (PFPE), perfluoro-15-crown-5-ether (PFCE), and perfluorooctyl bromide (PFOB) were measured in phantoms and in several different conditions (cell types, presence of fixation agent, and temperatures). These relaxation times were used to optimize pulse sequences through numerical simulations. The acquisition efficiency in each cellular condition was then determined as the ratio of the signal after optimization with the reference relaxation times and after optimization with its proper relaxation times. Finally, PFC detection limits were determined. RESULTS: The loss of acquisition efficiency due to parameter settings optimized for the wrong temperature and cellular condition was limited to 13%. The detection limits of all PFCs were lower at 24 °C than at 37 °C and varied from 11.8 ± 3.0 mM for PFCE at 24 °C to 379.9 ± 51.8 mM for PFOB at 37 °C. CONCLUSION: Optimizing 19 F pulse sequences with a known phantom only leads to moderate loss in acquisition efficiency in cellular conditions that might be encountered in in vivo and in vitro experiments. Magn Reson Med 77:2263-2271, 2017.
Authors: Christian Prinz; Paula Ramos Delgado; Thomas Wilhelm Eigentler; Ludger Starke; Thoralf Niendorf; Sonia Waiczies Journal: MAGMA Date: 2018-12-04 Impact factor: 2.310
Authors: Samuel A Einstein; Emily A Thompson; Chunxiao Guo; Elizabeth M Whitley; James A Bankson; Erik N K Cressman Journal: J Vasc Interv Radiol Date: 2019-09-16 Impact factor: 3.464
Authors: Amin Haghighat Jahromi; Chao Wang; Stephen R Adams; Wenlian Zhu; Kazim Narsinh; Hongyan Xu; Danielle L Gray; Roger Y Tsien; Eric T Ahrens Journal: ACS Nano Date: 2018-12-07 Impact factor: 15.881
Authors: Ruud B van Heeswijk; Roberto Colotti; Emeline Darçot; Jean Delacoste; Maxime Pellegrin; Davide Piccini; Diego Hernando Journal: Magn Reson Med Date: 2017-09-01 Impact factor: 4.668